Pipeline

Preclinical

Phase 1

Phase 2

Phase 3

XF-73 Nasal

Prevention of post-surgical staphylococcal infection (US QIDP and Fast Track status)

XF-73 Dermal

Treatment of skin infections of antibiotic resistant bacteria associated with open wounds / broken skin

Project 1 – Treatment of skin infections of antibiotic resistant bacteria associated with burns and open wounds

Project 2 – Treatment of superficial skin infections of antibiotic resistant bacteria

XF-73 Drugs Research

Treatment of antibiotic resistant biofilm and bacterial aggregate associated infections. Respiratory/dermal/oral mucositis

XF-73 Nasal

…and is a novel compound being developed for the prevention of post-surgical Staphylococcal infections.

XF-73 Dermal

...and has been supported by the US government’s National Institute for Allergy and Infectious Diseases, (part of the US National Institutes of Health).

XF-73 Drugs Research

...(including antibiotic resistant strains) leaving the bacteria unable to mount a resistance.